Charles McOsker, PhD

Dr. McOsker has over 30 years of experience in both the pharmaceutical and biotechnology industries. He brings an extensive background in the management of multifunctional teams in drug discovery and development to his role with BioMotiv.

Before joining BioMotiv in 2012, Dr. McOsker founded Airway Therapeutics, a biotechnology company created to develop promising therapeutics arising from within the pulmonary research program of Cincinnati Children’s Hospital Medical Center. At Airway Therapeutics, Dr. McOsker successfully managed the early stages of the company’s technology development and fundraising. Previously, Dr. McOsker served as Director of Business Development for the Drug Discovery Center at the University of Cincinnati where he was responsible for negotiating agreements with a potential value to the University of over $30 million. Dr. McOsker began his career at Procter & Gamble Pharmaceuticals. Over the course of 23 years, he held numerous management positions in drug discovery and development and was responsible for teams that discovered two products that successfully entered late-stage clinical development.

Dr. McOsker received his undergraduate degree in chemistry at Hope College in Michigan and his PhD in biochemistry and molecular biology at Cornell University.